Injective announces partnership with Andromeda
Injective announced a strategic partnership with Andromeda that will accelerate the adoption of DeFi by combining Andromeda's aOS and Injective's high-speed financial blockchain. Key highlights of the partnership include a seamless cross-chain portfolio, advanced DeFi applications, pass-through asset management and simplified segmentation of digital assets. The partnership will enhance cross-chain capabilities and simplify asset management, unlocking the full potential of next-generation Web3 applications.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bird’s controversial $XRP claim sparks heated debate among holders
Avici pledges full refunds as hackers hit Ajna next
Anthropic keeps Claude in Cursor as OpenAI pulls out over SpaceX deal
XRP ETFs Hit a New 2026 Record at $1.6 Billion
Crypto prices
More
